Sem Briongos Figuero

Dr. Sem Briongos Figuero

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2010 in Thorax
Verified
Journal Article
Open access
PDF file
DJDavid Jiménez
David Jiménez
DADrahomir Aujesky
Drahomir Aujesky
LMLisa Moores
Lisa Moores
VGVicente Gómez
Vicente Gómez
DMDavid Marti-Sanchez
David Marti-Sanchez
RYRoger D Yusen
Roger D Yusen
Background In haemodynamically stable patients with acute symptomatic pulmonary embolism (PE), studies have not evaluated the usefulness of combining the measurement of cardiac troponin, transthoracic echocardiogram (TTE), and lower extremity complete compression ultrasound (CCUS) testing for predicting the risk of PE-related death. Methods The study assessed the ability of three diagnostic tests (cardiac troponin I (cTnI), echocardiogram, and CCUS) to prognosticate the primary outcome of PE-related mortality during 30 days of follow-up after a diagnosis of PE by objective testing. Results Of 591 normotensive patients diagnosed with PE, the primary outcome occurred in 37 patients (6.3%; 95% CI 4.3% to 8.2%). Patients with right ventricular dysfunction (RVD) by TTE and concomitant deep vein thrombosis (DVT) by CCUS had a PE-related mortality of 19.6%, compared with 17.1% of patients with elevated cTnI and concomitant DVT and 15.2% of patients with elevated cTnI and RVD. The use of any two-test strategy had a higher specificity and positive predictive value compared with the use of any test by itself. A combined three-test strategy did not further improve prognostication. For a subgroup analysis of high-risk patients, according to the pulmonary embolism severity index (classes IV and V), positive predictive values of the two-test strategies for PE-related mortality were 25.0%, 24.4% and 20.7%, respectively. Conclusions In haemodynamically stable patients with acute symptomatic PE, a combination of echocardiography (or troponin testing) and CCUS improved prognostication compared with the use of any test by itself for the identification of those at high risk of PE-related death.

1 April 2012 in Chest
Verified
Journal Article
Closed access
PDF file
MLMareike Lankeit
Mareike Lankeit
VGVicente Gómez
Vicente Gómez
CWCarolin Wagner
Carolin Wagner
DADrahomir Aujesky
Drahomir Aujesky
MRMónica Recio
Mónica Recio
IGInstituto Ramón y Cajal de Investigación Sanitaria Pulmonary Embolism Study Group
Instituto Ramón y Cajal de Investigación Sanitaria Pulmonary Embolism Study Group

1 March 2010 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
LML. Moores
L. Moores
DAD. Aujesky
D. Aujesky
DJD. Jiménez
D. Jiménez
GDG. Díaz
G. Díaz
VGV. Gómez
V. Gómez
RYR. Yusen
R. Yusen

4 August 2014 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
DKDita Kopecna
Dita Kopecna
SFSem Briongos Figuero
Sem Briongos Figuero
HCHugo del Castillo
Hugo del Castillo
CMCarlos Moreno
Carlos Moreno
MRMónica Recio
Mónica Recio
FIfor the PROTECT investigators
for the PROTECT investigators
To evaluate the interobserver reliability of echocardiographic findings of right ventricle (RV) dysfunction for prognosticating normotensive patients with pulmonary embolism (PE). A central panel of cardiologists evaluated echocardiographic studies of 75 patients included in the PROTECT study for the following signs: RV diameter, RV/left ventricular (LV) diameter ratio, hypokinesis of the RV free wall, and tricuspid plane systolic excursion (TAPSE). Investigators used intraclass correlation to assess agreement between the measurements of the central panel and each of the local cardiologists. Investigators used the single weighted kappa statistic to test for agreement between readers of interpretation of RV enlargement and RV hypokinesis. The two observers had fair agreement (k = 0.45) for RV enlargement assessed by the RV diameter, and good agreement (k = 0.65) for RV enlargement assessed by the RV/LV diameter ratio. The interobserver reliability of the assessment whether hypokinesis of the RV free wall is present was good (к = 0.70), and whether RV dysfunction (assessed by TAPSE measurement) is present was very good (k = 0.86). The intraclass correlation for the RV/LV diameter ratio was fair (0.55; 95% confidence interval [CI], 0.37-0.69), for the RV diameter was good (0.70; 95% CI, 0.56-0.80), and for the TAPSE measurement was very good (0.85; 95% CI, 0.77-0.90). On Bland-Altman analysis, the mean differences for RV diameter, RV/LV diameter ratio and TAPSE measurement were 2.33 (±5.38), 0.06 (±0.23) and 0.08 (±2.20), respectively. TAPSE measurement is the least user dependent and most reproducible echocardiographic finding of RV dysfunction in normotensive patients with PE.

24 January 2023 in EP Europace
Verified
Journal Article
Open access
SFSem Briongos Figuero
Sem Briongos Figuero
ÁEÁlvaro Estévez-Paniagua
Álvaro Estévez-Paniagua
ASAna Sánchez-Hernández
Ana Sánchez-Hernández
RMRoberto Muñoz-Aguilera
Roberto Muñoz-Aguilera
Aims: Most of the criteria used to diagnose direct capture of the left bundle branch (LBB) have never been validated in an external sample. We hypothesized that lead aVL might add relevant information, and the combination of several electrocardiograph (ECG)-based criteria might discriminate better LBB capture from left ventricular septal (LVS) capture, than each criterion separately.Methods and results: Single-centre study involving all consecutive patients who received LBB area pacing. LBB capture was defined according to QRS morphology transition criteria during decremental pacing. Multivariate logistic regression analysis was performed to develop a predictive score for LBB capture. A total of 71 patients with confirmed LBB capture were analysed. The optimal cut-off values of R wave peak time (RWPT) in lead V6 (V6-RWPT) and V6-V1 interpeak interval for the discrimination of LBB capture were <83 ms and ≥33 ms, respectively. The RWPT in lead aVL (aVL-RWPT) showed a good discrimination power for the differential diagnosis of LBB capture and LVS capture. The optimal value for aVL-RWPT was 79 ms [sensitivity (SN) and specificity (SP) of 71.2% and 88.4%, respectively]. A new score, with a good diagnostic performance (area under the curve of 0.976), was constructed gathering the information from V6-RWPT, aVL-RWPT, and V6-V1 interpeak interval. The optimal score of 3 points showed a SN and SP of 89.2% and 100%, respectively for the differentiation of LBB capture.Conclusions: ECG-based criteria are useful to confirm the capture of the LBB. The combination of V6-RWPT, aVL-RWPT, and V6-V1 interpeak interval values demonstrated better diagnostic performance than isolated measurements.

9 June 2015 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
SFSem Briongos Figuero
Sem Briongos Figuero
JMJosé Luis Moya Mur
José Luis Moya Mur
Alberto García-LledoAlberto García-Lledo
Alberto García-Lledo
TCTomasa Centella
Tomasa Centella
LSLuisa Salido
Luisa Salido
JZJosé Luis Zamorano
José Luis Zamorano